First, we discuss the CDC's about-face on mask wearing, the debate over vaccine booster shots, and the slow but steady race to develop pills for Covid-19. Then, STAT's Kate Sheridan joins us to discuss a setback in the field of microbiomics and the mounting skepticism over whether tinkering with gut bacteria can eventually treat a host of diseases. We also break down the latest fallout from the FDA's approval of Aduhelm, the sorry state of biotech stocks, and an in-development feature film about CRISPR.
The Readout Loud